- PepperLime Health priced a 15M IPO at $10/unit which will be listed on the Nasdaq under the symbol, "PEPLU"; underwriters granted 45-day option to purchase up to an additional 2.25M units.
- Each unit consists of one Class A ordinary share and one-half of one warrant wherein the warrant holder will purchase one Class A ordinary share at $11.5/share.
- Offer is expected to close on Oct.19.
- While the company may pursue an initial business combination target in any business or industry, it intends to target companies at the intersection of technology and consumer health and wellness.
- Proceeds will be used to fund the business combination.